BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35437865)

  • 21. Daylight photodynamic therapy with ablative carbon dioxide fractional laser for treating actinic keratosis in Asians: A case series.
    Yoon J; Kim YC
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101905. PubMed ID: 32619714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of 10 efficient protocols for photodynamic therapy of actinic keratosis: How relevant are effective light dose and local damage in predicting the complete response rate at 3 months?
    Vignion-Dewalle AS; Baert G; Thecua E; Lecomte F; Vicentini C; Abi-Rached H; Mortier L; Mordon S
    Lasers Surg Med; 2018 Jul; 50(5):576-589. PubMed ID: 29667728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Photodynamic therapy-trends and new developments].
    Szeimies RM; Karrer S
    Hautarzt; 2021 Jan; 72(1):27-33. PubMed ID: 33301063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia.
    See JA; Shumack S; Murrell DF; Rubel DM; Fernández-Peñas P; Salmon R; Hewitt D; Foley P; Spelman L
    Australas J Dermatol; 2016 Aug; 57(3):167-74. PubMed ID: 26033230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-Aminolevulinic acid-mediated photodynamic therapy to superficial malignant skin tumors using Super Lizer.
    Hirata Y; Koga S; Fukui N; Yu A; Koshida S; Kosaka Y; Kurokawa T; Moriwaki S
    J Dermatol; 2011 Aug; 38(8):748-54. PubMed ID: 21352331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conventional versus daylight photodynamic therapy for actinic keratosis: A randomized and prospective study in China.
    Zhu L; Wang P; Zhang G; Zhang L; Liu X; Hu C; Yang X; Sroka R; Zhou Z; Wang X
    Photodiagnosis Photodyn Ther; 2018 Dec; 24():366-371. PubMed ID: 30336290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Daylight photodynamic therapy with methyl aminolevulinate cream is as effective as conventional photodynamic therapy with blue light in the treatment of actinic keratosis: a controlled randomized intra-individual study.
    Assikar S; Labrunie A; Kerob D; Couraud A; Bédane C
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1730-1735. PubMed ID: 31955461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Daylight photodynamic therapy is an option for the treatment of actinic keratosis in patients with xeroderma pigmentosum in Africa.
    Fernández-Guarino M; Mavura D; Fernández-González P; Chapa P; Ravazzano C; Jaén L; Rios L; Jaén P; Grossman H
    Photodiagnosis Photodyn Ther; 2020 Mar; 29():101631. PubMed ID: 31904551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Daylight photodynamic therapy with MAL cream for large-scale photodamaged skin based on the concept of 'actinic field damage': recommendations of an international expert group.
    Philipp-Dormston WG; Sanclemente G; Torezan L; Tretti Clementoni M; Le Pillouer-Prost A; Cartier H; Szeimies RM; Bjerring P
    J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):8-15. PubMed ID: 26552049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-level light-assisted photodynamic therapy using a wearable cap-like device for the treatment of actinic keratosis of the scalp.
    Fonda-Pascual P; Alegre-Sánchez A; Harto-Castaño A; Moreno-Arrones OM; Pérez-García B; González-Morales ML; Pindado-Ortega C; Gilaberte-Calzada Y; Aguilera J; Jaen-Olasolo P; Fernández-Guarino M
    Photodiagnosis Photodyn Ther; 2019 Mar; 25():136-141. PubMed ID: 30508663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined daylight and conventional photodynamic therapy with 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis of the face and scalp: a new and efficient approach.
    Salido-Vallejo R; Jiménez-Nájar F; Garnacho-Sucedo G; Vélez A
    Arch Dermatol Res; 2020 Nov; 312(9):675-680. PubMed ID: 31838569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A consensus on the use of daylight photodynamic therapy in the UK.
    Ibbotson S; Stones R; Bowling J; Campbell S; Kownacki S; Sivaramakrishnan M; Valentine R; Morton CA
    J Dermatolog Treat; 2017 Jun; 28(4):360-367. PubMed ID: 27788605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study.
    Wiegell SR; Fabricius S; Gniadecka M; Stender IM; Berne B; Kroon S; Andersen BL; Mørk C; Sandberg C; Ibler KS; Jemec GB; Brocks KM; Philipsen PA; Heydenreich J; Hædersdal M; Wulf HC
    Br J Dermatol; 2012 Jun; 166(6):1327-32. PubMed ID: 22250644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of clinical and histologic findings in daylight photodynamic therapy for skin field cancerization: A randomized controlled four-arm study on physical methods-assisted delivery of methyl aminolevulinate.
    Bento CO; Pantaleão L; de Souza MB; Vilar EAG; Luiz RR; Filho PJS; Gismondi RAOC; Issa MCA
    Photodiagnosis Photodyn Ther; 2021 Sep; 35():102404. PubMed ID: 34133958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Studies of methyl aminolevulinate photodynamic therapy for actinic keratosis].
    Fernández-Guarino M; Harto A; Jaén P
    Actas Dermosifiliogr; 2010 May; 101(4):315-22. PubMed ID: 20487686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photodynamic therapy: a review of the literature and image documentation.
    Issa MC; Manela-Azulay M
    An Bras Dermatol; 2010; 85(4):501-11. PubMed ID: 20944910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Innovation in the treatment of non-melanoma skin cancer: daylight photodynamic therapy].
    Ágoston D; Ócsai H; Ignácz F; Viharosné Dósa-Rácz É; Rárosi F; Oláh J; Kemény L; Baltás E
    Orv Hetil; 2022 Sep; 163(36):1422-1429. PubMed ID: 36057871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
    Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
    G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of 5-Aminolevulinic Acid and Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses.
    Shive ML; Coakley BJ; Bierman DF; Serowka Lane KL; Wiegell SR; Haedersdal M; Zachary CB
    Dermatol Surg; 2019 Apr; 45(4):529-535. PubMed ID: 30807390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Daylight photodynamic therapy in 25 patients with actinic keratosis and evaluation of efficacy by confocal microscopy.
    Sousa ACDS; Campos MAC; Baptista AM; Menezes NMBVN
    Photodiagnosis Photodyn Ther; 2019 Mar; 25():414-416. PubMed ID: 30721758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.